Association of NAT2 gene substitution mutation T341C with increased risk for head and neck cancer in Tunisia.

References

• Cloos J, Spitz MR, Schaniz SP, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Nail Cancer Inst. 1996; 88: 530–5
   PubMed Web of Science ®Google Scholar
• Risch A, Ramroth H, Raedts V, et al. Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADIIIB and ADIIIC, and glutathione S-transferases GSTM1 and GSTT1. Pharmacogenetics 2003; 13: 225–30
   PubMedGoogle Scholar
• Olshan AF, Weissler MC, Walson MA, Bell DA. GSTM1, GSTT1, GSTP1, CYPIA1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2000; 9: 185–91
   PubMed Web of Science ®Google Scholar
• Kietthubthew S, Sriplung H, Au WW. Genetic and environnemental interactions on oral cancer in southern Thailand. Environ Mol Mutagen. 2003; 37: 111–6
   Google Scholar
• Chen C, Ricks S, Doody DR, Fitzgibbons ED, Porter PL, Schwartz SM. N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk. Carcinogenesis. 2001; 22: 1993–1999
   PubMed Web of Science ®Google Scholar
• Nizar- VS, Vaughan TL, Burt RD, Chen C, Berwik MG, Swanson M. Glutathione S transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol. Biomark. Prev. 1999; 8: 547–551
   Google Scholar
• Murat Aoenal M, Laiafer Tamer PhD, , Nurcan Aras Ates PhDet al Glutathione S-transferase M1, T1, and P1 gene polymorphism in laryngeal squamous cell carcinoma. Am J Otolaryngol 2004;25:318–22.
   PubMed Web of Science ®Google Scholar
• Shama C. Buch, Perin N. Notani, Rajani A. Bhisey. Polymorphism at GSTM1, GSTM3, and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis. 2002;23:803–807.
   PubMed Web of Science ®Google Scholar
• Butcher NJ, Boukouvala S, Sim E, Minchin RF. Pharmacogenetics of the arylamine N-acetyltransferases. The pharma J 2002; 2: 30–42
   Google Scholar
• Hamdy SI, Hiratsuka M, Narahara K, et al. Genotype and allele frequencies of TPMT, NAT2, GST, SULTIAI and MDR-I in the Egyptian population. Br J Clin Pharmacol 2003; 55: 560–569
   PubMed Web of Science ®Google Scholar
• Seidegard J, Pero R. the hereditary transmission of the high GST activity towords trans-stilbene oxide in the human mononuclear leukocytes. Human genetics 1985; 69: 66–68
   PubMed Web of Science ®Google Scholar
• Pemble S, Schroeder K, Spencer S, et al. Human glutatione s-transferase theta (GSTT1): cDNA cloning and the charachterization of a genetic polymorphism. Biochem J 1994; 300: 271–6
   PubMed Web of Science ®Google Scholar
• Longuemaux S, Deloménie C, Gallou C, Méjean A, Dupret JM. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 1999; 59: 2903–2908
   PubMed Web of Science ®Google Scholar
• Hahn M, Hagedorn G, Kuhlisch E, Schackert KH, Eckelt U. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncology 2002; 38: 486–490
   PubMed Web of Science ®Google Scholar
• Mc Williams JE, Evans AJ, Beer TM, et al. Genetic polymorphisms in head and neck cancer risk. Head Neck 2000; 22(6)609–17
   PubMed Web of Science ®Google Scholar
• Park LY, Muscat JE, Kaur T, et al. Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and caucasiens. Pharmacogenetics 2000; 10(2)123–31
   PubMedGoogle Scholar
• Hahn M, Hagedorn G, Kuhlisch E, Schackert KH, Eckelt U. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncology 2002; 38: 486–490
   PubMed Web of Science ®Google Scholar
• Gronau S, Koning Creger D, Rettinger G, Riechelmann H. GSTM1 gene polymorphism in patients with head and neck tumors. Laryngorhinootologie 2000; 79(6)341–4
   PubMed Web of Science ®Google Scholar
• Miki S, Takayuki S, Toshiyuki I, Teruo A. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999; 20: 1927–1931
   PubMed Web of Science ®Google Scholar
• Garte S. the role of ethnicity in cancer susceptibility gene polymorphisms the example of CYP1A1. Carcinogenesis 1998; 19: 1329–32
   PubMed Web of Science ®Google Scholar
• Mareux PM, Vineis P, Rothman N. NAT2 slow acetylation and bladder cancer risk, meta-analysis of 22 case-control studies concludedin the general population. Pharmacogenetics 2000; 10: 115–22
   PubMedGoogle Scholar
• Ye Z, Song H, Guo Y. Gluthathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis. BMJ 2004; 41: 360–365
   Google Scholar
• Gonzalez MV, Alvarez V, Pello MF, Menéndez MJ, Suarez C, Coto E. Genetic polymorphism of N-acetyltransferase-2, gluthatione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J Clin Pathol 1998; 51: 294–298
   PubMed Web of Science ®Google Scholar
• Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutation Res 2002; 506–507: 65–77
   PubMed Web of Science ®Google Scholar